Latest Phosphorylation Stories
Scientists report they can crank up insect aggression simply by interfering with a basic metabolic pathway in the insect brain.
The Life, Earth & Health Sciences Magazine has reorganized its structure to facilitate interaction with users.
Live webinar to focus on using quantitative phosphoproteomics to support the discovery and development of kinase-selective drugs.
The Protein Society, the leading international society devoted to furthering research and development in protein science, announces the winners of its 2013 Awards.
Fetal alcohol syndrome is the leading preventable cause of developmental disorders in developed countries.
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.
Scientists at The Scripps Research Institute have simultaneously mapped two of the most important types of protein-modification in cells, revealing their extensive cooperation during an essential cellular process.